DEMOPLANNED · PHASE 2
console.markable.health / rtm
PLANNED PATHWAYThis model becomes available only after MARKABLE registers as a Class I Software as a Medical Device. Not billable today. Figures are 2026 CMS-benchmarked and illustrative.
MARKABLERTM Routine
Planned reimbursement pathway

How MARKABLE's monthly routine is designed to fit RTM.

Phase 2, not today. MARKABLE is currently a general-wellness platform, not an FDA medical device. RTM billing requires the monitoring tool to legally be an FDA-defined device. What follows illustrates the routine and the running requirements a clinic would meet once MARKABLE is registered as a Class I Software as a Medical Device. It is not billable today, and it is investor and partner material only.